Spread the love

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular therapy for Metabolic disorders: RREB (Ras responsive element binding protein) increases insulin sensitivity, restores mucosal immunity and decreases endotoxaemia via up regulation of Interleukin-22 (IL-22), 16/October/2014, 6.34 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance: This study suggests, for the first time, that RREB, by increasing the expression of IL-22, it may increase insulin sensitivity, restore gut immunity and decrease endotoxaemiaTogether, this study suggests that pharmacological formulations encompassing “RREB activators” may be used to treat metabolic disorders, including T2DM and cardiac diseases.


Spread the love